Glaucoma is one of the leading causes of permanent blindness in the world, affecting more than two million Americans, and more than one hundred million people worldwide. It is a disease of the optic ...

Over 2 million Americans have glaucoma, and half of them are unaware that their vision is slowly deteriorating, according to the Glaucoma Research Foundation. Glaucoma is a leading cause of blindness, ...

ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient has been treated in its U.S.

Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...

A practice has purchased a new piece of scanning laser equipment (GDx) that is designed to help in the early detection of glaucoma. In the past, the practice always billed for a visual field and ...

A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option. Neil Minkoff, MD: As we move into different types of therapy, laser ...

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...

Purpose To detect differences in retinal nerve fibre layer (RNFL) measurements between patients with acute angle-closure glaucoma (AACG) and normal subjects using scanning laser polarimetry. Methods ...

Aims To assess efficacy of trans-scleral diode laser cyclophotocoagulation in the treatment of diabetic neovascular glaucoma refractory to medical therapy. Methods Case notes of 20 eyes of 20 patients ...

LOS ANGELES & MUNICH--(BUSINESS WIRE)--ELT Sight, Inc. today announced the company has acquired the IP and assets of MLase AG’s excimer ophthalmic laser system for glaucoma surgery. MLase manufactures ...